Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Lexaria Bioscience stock | $6.45

Learn how to easily invest in Lexaria Bioscience stock.

Lexaria Bioscience Corp
NASDAQ: LEXX - USD
BIOTECHNOLOGY
$6.45
- $0.14 ( - 2.12%)

Lexaria Bioscience, a Kelowna, Canada-based company that develops drug delivery platforms, is seeking a listing on the Nasdaq. The company is currently listed on the Over-the-Counter Markets under the ticker "LXRP," as well as the Canadian Securities Exchange under the ticker symbol "LXX."

How to buy shares in Lexaria Bioscience

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LEXX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Lexaria Bioscience stock price (NASDAQ: LEXX)

Use our graph to track the performance of LEXX stocks over time.

Lexaria Bioscience shares at a glance

Information last updated 2021-10-23.
Latest market close$6.45
52-week range$4.11 - $10.50
50-day moving average $6.55
200-day moving average $6.24
Wall St. target price$12.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.97

Buy Lexaria Bioscience shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Lexaria Bioscience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lexaria Bioscience price performance over time

Historical closes compared with the close of $6.45 from 2021-10-25

1 week (2021-10-19) -5.29%
1 month (2021-09-24) -5.98%
3 months (2021-07-26) -4.73%
6 months (2021-04-26) 21.70%
1 year (2020-10-26) 3,386.49%
2 years (2019-10-25) 821.43%
3 years (2018-10-26) 330.00%
5 years (2016-10-26) 2,171.13%

Lexaria Bioscience financials

Revenue TTM $825,456
Gross profit TTM $276,925
Return on assets TTM -42.56%
Return on equity TTM -54.36%
Profit margin 0%
Book value $2.03
Market capitalisation $37.7 million

TTM: trailing 12 months

Shorting Lexaria Bioscience shares

There are currently 338,984 Lexaria Bioscience shares held short by investors – that's known as Lexaria Bioscience's "short interest". This figure is 5.5% down from 358,862 last month.

There are a few different ways that this level of interest in shorting Lexaria Bioscience shares can be evaluated.

Lexaria Bioscience's "short interest ratio" (SIR)

Lexaria Bioscience's "short interest ratio" (SIR) is the quantity of Lexaria Bioscience shares currently shorted divided by the average quantity of Lexaria Bioscience shares traded daily (recently around 325946.15384615). Lexaria Bioscience's SIR currently stands at 1.04. In other words for every 100,000 Lexaria Bioscience shares traded daily on the market, roughly 1040 shares are currently held short.

To gain some more context, you can compare Lexaria Bioscience's short interest ratio against those of similar companies.

However Lexaria Bioscience's short interest can also be evaluated against the total number of Lexaria Bioscience shares, or, against the total number of tradable Lexaria Bioscience shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Lexaria Bioscience's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Lexaria Bioscience shares in existence, roughly 60 shares are currently held short) or 0.0726% of the tradable shares (for every 100,000 tradable Lexaria Bioscience shares, roughly 73 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Lexaria Bioscience.

Find out more about how you can short Lexaria Bioscience stock.

Lexaria Bioscience share dividends

We're not expecting Lexaria Bioscience to pay a dividend over the next 12 months.

You may also wish to consider:

Have Lexaria Bioscience's shares ever split?

Lexaria Bioscience's shares were split on a 1:30 basis on 11 January 2021. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lexaria Bioscience shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Lexaria Bioscience shares which in turn could have impacted Lexaria Bioscience's share price.

Lexaria Bioscience share price volatility

Over the last 12 months, Lexaria Bioscience's shares have ranged in value from as little as $4.11 up to $10.5. A popular way to gauge a stock's volatility is its "beta".

LEXX.US volatility(beta: 1.51)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lexaria Bioscience's is 1.5079. This would suggest that Lexaria Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Lexaria Bioscience's beta into context you can compare it against those of similar companies.

Lexaria Bioscience overview

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada. .

Frequently asked questions

What percentage of Lexaria Bioscience is owned by insiders or institutions?
Currently 16.775% of Lexaria Bioscience shares are held by insiders and 8.177% by institutions.
How many people work for Lexaria Bioscience?
Latest data suggests 4 work at Lexaria Bioscience.
When does the fiscal year end for Lexaria Bioscience?
Lexaria Bioscience's fiscal year ends in August.
Where is Lexaria Bioscience based?
Lexaria Bioscience's address is: 100 ? 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7
What is Lexaria Bioscience's ISIN number?
Lexaria Bioscience's international securities identification number is: US52886N4060

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site